Angiogenic growth factors potential new treatment for acute myocardial infarction?
Open Access
- 14 January 2000
- journal article
- review article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 45 (2) , 294-302
Abstract
In models of hind-limb ischemia and progressive coronary artery occlusion, angiogenic growth factor proteins and genes expressing growth factors have been shown to induce the development of collateral vessels and remodeling of existing collaterals. The therapeutic potential of growth factors in the setting of acute myocardial infarction may be related to non-angiogenic properties of growth factors as well, and is the focus of this review.Keywords
This publication has 6 references indexed in Scilit:
- Intramyocardial Infusion of FGF-1 Mimics Ischemic Preconditioning in Pig MyocardiumJournal of Molecular and Cellular Cardiology, 1998
- Continuous administration of insulin-like growth factor-I and basic fibroblast growth factor does not affect left ventricular geometry after acute myocardial infarction in ratsInternational Journal of Cardiology, 1998
- Heparin protects basic and acidic FGF from inactivationJournal of Cellular Physiology, 1986
- Human Basic Fibroblast Growth Factor: Nucleotide Sequence, Genomic Organization, and Expression in Mammalian CellsCold Spring Harbor Symposia on Quantitative Biology, 1986
- Fibroblastic Growth Factor and Infarct SizeAnnals of Internal Medicine, 1980
- Collateral blood flow in conscious dogs with chronic coronary artery occlusionAmerican Journal of Physiology-Legacy Content, 1971